scholarly journals Compressive Optic Neuropathy Secondary to Sinonasal Undifferentiated Carcinoma in a Young Male

Cureus ◽  
2021 ◽  
Author(s):  
Maizatul Nadia Hassan ◽  
Wan Hazabbah Wan Hitam ◽  
Nurul Ain Masnon ◽  
Subash Govindasamy ◽  
Ahmad Razif Omar
Keyword(s):  
Optic Neuropathy ◽  
Young Male ◽  
Undifferentiated Carcinoma ◽  
Compressive Optic Neuropathy ◽  
Sinonasal Undifferentiated Carcinoma

Primary Sinonasal Undifferentiated Carcinoma Presenting With Bilateral Retrobulbar Optic Neuropathy

2007 ◽  
Vol 27 (3) ◽  
pp. 189-192 ◽  
Author(s):  
Madhura A Tamhankar ◽  
Nicholas J Volpe ◽  
Laurie A Loevner ◽  
James N Palmer ◽  
Michael Feldman
Keyword(s):  
Optic Neuropathy ◽  
Undifferentiated Carcinoma ◽  
Sinonasal Undifferentiated Carcinoma

An Unusual Optic Neuropathy Case Caused by Sinonasal Undifferentiated Carcinoma

2008 ◽  
Vol 32 (6) ◽  
pp. 299-302
Author(s):  
Ying-Jen Chen ◽  
Jiann-Torng Chen ◽  
Po-Liang Chen
Keyword(s):  
Optic Neuropathy ◽  
Undifferentiated Carcinoma ◽  
Sinonasal Undifferentiated Carcinoma

Incidence and Survival Patterns of Sinonasal Undifferentiated Carcinoma in the United States

2014 ◽  
Vol 75 (S 01) ◽  
Author(s):  
Kyle Chambers ◽  
Ashton Lehmann ◽  
Aaron Remenschneider ◽  
Matthew Dedmon ◽  
Bharat Yarlagadda ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Undifferentiated Carcinoma ◽  
Sinonasal Undifferentiated Carcinoma ◽  
Survival Patterns

Multidisciplinary Management of Sinonasal Undifferentiated Carcinoma

Skull Base ◽  
2007 ◽  
Vol 17 (S 2) ◽  
Author(s):  
Vu Ho ◽  
Daniel Ward ◽  
Erin Lin ◽  
Jason Heth ◽  
Janet Urban ◽  
...  
Keyword(s):  
Undifferentiated Carcinoma ◽  
Multidisciplinary Management ◽  
Sinonasal Undifferentiated Carcinoma

Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma

2021 ◽  
Vol 39 (3) ◽  
pp. 235-239
Author(s):  
Hannah Robinson ◽  
Michelle Green ◽  
Gauri Radkar ◽  
Neal Ready ◽  
John Strickler
Keyword(s):  
Undifferentiated Carcinoma ◽  
Sinonasal Undifferentiated Carcinoma ◽  
Met Amplification

Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab

2021 ◽  
pp. 112067212199104
Author(s):  
Catherine J Hwang ◽  
Erin E Nichols ◽  
Brian H Chon ◽  
Julian D Perry
Keyword(s):  
Side Effects ◽  
Optic Neuropathy ◽  
Surgical Decompression ◽  
Thyroid Eye Disease ◽  
Eye Disease ◽  
High Dose ◽  
Compressive Optic Neuropathy ◽  
Traditional Management ◽  
Immune Mediated ◽  
Orbital Radiation

Thyroid eye disease is an auto-immune mediated orbitopathy which can cause dysthyroid compressive optic neuropathy. Traditional management of active thyroid eye disease includes temporizing high-dose steroids, orbital radiation and surgical decompression, which each possess significant limitations and/or side effects. Teprotumumab is an IGF-IR inhibitor recently FDA-approved for active thyroid eye disease. The authors report reversal of bilateral dysthyroid compressive optic neuropathy managed medically utilizing teprotumumab.

Sign in / Sign up

Export Citation Format

Share Document